1Azziz R, Nestler JE. Androgen excess disorders in women, polycystic ovary syndrome and other disorders [ M ]. Totowa, New Jersey : Humana press ,2006:2.
2Laven JSE, Imani B. New approach to polyscystic ovary syndrome and other forms of anovulatory infertility [ J ]. Obstet Gynecol Surv,2002, 57(7) :55 -67.
3Ruchi Mathur, Olga Levin. Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome[ J]. Therapeutics and Clinical Risk Management ,2008,4 (2) :487 - 492.
4Vrbikova J, Cibula D. Combined oral contraceptives in the treatment of polycystic ovary syndrome [ J ]. Hum Reprod Update,2005,11 (2) : 77 -91.
5Wiegratez I, Kutschera E. Effect of four different oral contraceptives on various sex hormones and serum - binding globulins [ J ]. Contraception ,2003,67:25 - 32.
6Creatsas G, Koliopoulos C. Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome [ J ]. Lipid profile, 2002,900(2) :45 -52.
7Pehlivanov B, Mitkov M. Efficacy of an oral contraceptive containing drospirenonc in the treatment of women with polycystic ovary syndrome [ J ]. Eur J Contracept Reprod Health Care,2007,12 ( 3 ) :5.
8Guido M, Romualdi D. Drospirenone for the treatment of hirsute women with polycystic ovary syndrome : a clinical, endocrinological, metabolic pilot study [ J ]. Clin Endocrinol Metab,2004,89 ( 28 ) : 17 -23.
9De Leo V, Morgante G, Piomboni P, et al. Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperrandrogenic women with polycystic ovary syndrme[ J ]. Fertil Steril,2007,88 (11 ) :3 -7.
10Palep - Singh M, Mook K. An observational study of Yasmin in the management of women with polycystic ovary syndrome [ J ]. J Fam Plann Reprod Health Care,2004,30(16) :3 -5.
